Overview
Legal name
ADAPTIVE DIAGNOSTICS LIMITED
Region
South East England
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Adaptive Diagnostics Limited
Point-of-Care Diagnostics | Adaptive Dx
Adaptive DX is preventing the spread of disease by integrating nanotechnology, medical devices and software into a new type of point-of-care diagnostic test.
CRN
11949213
Founded
2019
Age
6
Company events
Reference milestones and recent Companies House filing stream events.
2 events
22 Oct
2024
Gazette Dissolved Compulsory
GazetteGAZ2 | Transaction MzQzOTYzNDc4MWFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 01:35
16 Apr
2019
Incorporated
InceptionCompany registered at Companies House
Public funding
1 award
First funded
2020
Funded years
2020
Age at first award
1 years
Projects
2020
Feasibility Studies
Lead participant
Rapid swab-based point-of-care antigen testing assay proof-of-concept for the detection of SARS-CoV-2
1 Jun 2020 to 31 Mar 2021
Awarded
£68,803
Total cost £68,803
The COVID-19 pandemic has had a direct effect on the livelihoods of millions here at home in the UK. Unfortunately, the restrictions set on our daily lives will persist until a coronavirus test is widely adopted. Adaptive Diagnostics have made it our mission to create a cheap, rapid and accurate saliva-based coronavirus test that can be used by all health...
Product types
Feasibility Studies